In vitro generation of influenza-specific polyfunctional CD4⁺ T cells suitable for adoptive immunotherapy

References

• Kharfan-Dabaja MA, Velez A, Richards K, Greene JN, Field T, Sandin R. Influenza A/pandemic 2009/H1N1 in the setting of allogeneic hematopoietic cell transplantation: a potentially catastrophic problem in a vulnerable population. Int J Hematol. 2010;91:124–7.
   PubMedGoogle Scholar
• Gooskens J, Jonges M, Claas EC, Meijer A, van den Broek PJ, Kroes AM. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus. Journal of the American Medical Assn. 2009;301:1042–6.
   PubMedGoogle Scholar
• Raboni SM, Nogueira MB, Tsuchiya LRV, Takahashi GA, Pereira LA, Pasquini R, . Respiratory tract viral infections in bone marrow transplant patients. Transplantation. 2003;76:142–6.
   PubMed Web of Science ®Google Scholar
• Ljungman P, Avetisyan G. Influenza vaccination in hematopoietic SCT recipients. Bone Marrow Transplant. 2008;42:637–41.
   PubMed Web of Science ®Google Scholar
• Avetisyan G, Aschan J, Hassan M, Ljungman P. Evaluation of immune responses to seasonal influenza vaccination in healthy volunteers and in patients after stem cell transplantation. Transplantation. 2008;86:257–63.
   PubMed Web of Science ®Google Scholar
• Ferguson P, Jordens C, Gilroy N. Patient and family education in HSCT: improving awareness of respiratory virus infection and influenza vaccination. A descriptive study and brief intervention. Bone Marrow Transplant. 2009;45:656–61.
   PubMedGoogle Scholar
• Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, . Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis. 2010;16:1068–75.
   PubMed Web of Science ®Google Scholar
• Garland P, de Lavallade H, Sekine T, Hoschler K, Sriskandan S, Patel P, . Humoral and cellular immunity to primary H1N1 infection in patients with hematological malignancies and following stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:632–9.
   PubMedGoogle Scholar
• Ison MG, Gubareva LV, Atmar RL, Treanor J, Hayden FG. Recovery of drug-resistant influenza virus from immunocompromised patients: a case series. J Infect Dis. 2006;193:760–4.
   PubMed Web of Science ®Google Scholar
• George B, Ferguson P, Kerridge I, Gilroy N, Gottlieb D, Hertzberg M. The clinical impact of infection with Swine flu (H1N1 09) strain of influenza virus in hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2010;17:147–53.
   PubMedGoogle Scholar
• Martino R, PiÒana J, Parody R, Valcarcel D, Sureda A, Brunet S, . Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplant. 2009;44:749–56.
   PubMed Web of Science ®Google Scholar
• Subbramanian RA, Basha S, Shata MT, Brady RC, Bernstein DI. Pandemic and seasonal H1N1 influenza hemagglutinin-specific T cell responses elicited by seasonal influenza vaccination. Vaccine. 2010;28:8258–67.
   PubMedGoogle Scholar
• Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, Sun H, . Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. New Engl J Med. 2009;361:1945–52.
   PubMed Web of Science ®Google Scholar
• Richards KA, Topham D, Chaves FA, Sant AJ. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus. J Immunol. 2010;185:4998–5002.
   PubMed Web of Science ®Google Scholar
• Tan P, Khan AM, August JT. Highly conserved influenza A sequences as T cell epitope-based vaccine targets to address the viral variability. Human Vacc. 2011;7:402–9.
   PubMed Web of Science ®Google Scholar
• Valkenburg SA, Rutigliano JA, Ellebedy AH, Doherty PC, Thomas PG, Kedzierska K. Immunity to seasonal and pandemic influenza A viruses. Microbes Infect. 2011;13:489–501.
   PubMed Web of Science ®Google Scholar
• Lee BO, Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Makris M, Sprague F, . CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol. 2005;175:5827–38.
   PubMed Web of Science ®Google Scholar
• Wolniak KL, Shinall SM, Waldschmidt TJ. The germinal center response. Crit Rev Immunol. 2004;24:39–65.
   PubMed Web of Science ®Google Scholar
• Stadtmauer EA, Vogl DT, Luning Prak E, Boyer J, Aqui NA, Rapoport AP, . Transfer of influenza vaccine-primed costimulated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial. Blood. 2011;117:63–71.
   PubMed Web of Science ®Google Scholar
• Aktas E, Kucuksezer UC, Bilgic S, Erten G, Deniz G. Relationship between CD107a expression and cytotoxic activity. Cell Immunol. 2009;254:149–54.
   PubMed Web of Science ®Google Scholar
• Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, . Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods. 2003;281:65–78.
   PubMed Web of Science ®Google Scholar
• Harari A, Cellerai C, Enders FB, Kostler J, Codarri L, Tapia G, . Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype. Proc Natl Acad Sci USA. 2007;104:16233–8.
   PubMedGoogle Scholar
• Younes SA, Yassine-Diab B, Dumont AR, Boulassel MR, Grossman Z, Routy JP, . HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med. 2003;198:1909–22.
   PubMed Web of Science ®Google Scholar
• Seidel A, Smith D, Yung E, Aquino L, Srivastava T, Pullarkat V, . CD154 Expression is associated with neutralizing antibody titer levels postinfluenza vaccination in stem cell transplant patients and healthy adults. Biol Blood Marrow Transplant. 2011;17:524–33.
   PubMedGoogle Scholar
• Muller M, Blum H, Er F, Thimme R, Semmo N. Cellular immune response in hepatitis C infection: role of CD154 expression and clinical relevance. Deutsche Med Wochenschrift (1946). 2011;136:1073–7.
   PubMedGoogle Scholar
• Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nature Med. [Res Support, NIH, Intramural]. 2005;11:1113–7.
   PubMed Web of Science ®Google Scholar
• Chevalier N, Jarrossay D, Ho E, Avery DT, Ma CS, Yu D, . CXCR5 expressing human central memory CD4 T cells and their relevance for humoral immune responses. J Immunol. 2011;186:5556–68.
   PubMed Web of Science ®Google Scholar
• Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB, Cannata-Ortiz J, . Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica. 2011;96:1231–5.
   PubMed Web of Science ®Google Scholar
• Tekgunduz E, Yuksel M, Erbay C, Aribas B, Ozdilekcan C, Arslan H, . Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: single center experience. Oncology. 2010;79:409–14.
   PubMedGoogle Scholar
• Wei JY, Chen FF, Jin J, Mai WY, Qian WB, Meng HT, . Novel influenza A (H1N1) in patients with hematologic disease. Leuk Lymph. 2010;51:2079–83.
   PubMed Web of Science ®Google Scholar
• Espinosa-Aguilar L, Green JS, Forrest GN, Ball ED, Maziarz RT, Strasfeld L, . Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers’ experiences. Biol Blood Marrow Transplant. 2011;17:566–73.
   PubMedGoogle Scholar
• Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;39:1300–6.
   PubMed Web of Science ®Google Scholar
• Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, . Seroprotective titers against 2009-H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011;17:434–8.
   PubMed Web of Science ®Google Scholar
• de Lavallade H, Garland P, Sekine T, Hoschler K, Marin D, Stringaris K, . Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host. Haematologica. 2011;96:307–14.
   PubMed Web of Science ®Google Scholar
• Mohty B, Bel M, Vukicevic M, Nagy M, Levrat E, Meier S, . Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients. Haematologica. 2011;96:896–904.
   PubMedGoogle Scholar
• Hanley PJ, Shaffer DR, Cruz CRY, Ku S, Zou BT, Liu H, . Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation. Cytotherapy. 2011;13:976–86.
   PubMed Web of Science ®Google Scholar
• Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein–Barr virus: an approach for adoptive immunotherapy of multiple pathogens. J Immunother. 2007;30:544–56.
   PubMedGoogle Scholar
• Leen AM, Myers GD, Sili U, Huls MH, Weiss H, Leung KS, . Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nature Med. 2006;12:1160–6.
   PubMed Web of Science ®Google Scholar
• Micklethwaite KP, Clancy L, Sandher U, Hansen AM, Blyth E, Antonenas V, . Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic sstem cell transplantation. Blood. 2008;112:3974–81.
   PubMed Web of Science ®Google Scholar
• Melenhorst JJ, Leen AM, Bollard CM, Quigley MF, Price DA, Rooney CM, . Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects. Blood. 2010;116:4700–2.
   PubMed Web of Science ®Google Scholar